Gosh, you’ve got to feel sorry for Pfizer. The poor drug giant has to pay taxes in our country, so it’s leaving.
When I say “poor” drug giant, I don’t mean Pfizer is broke or in the poor house. No, no, the pill peddler is incredibly rich, hauling in some $50 billion a year on sales of Viagra, Lipitor, Celebrex, and such. However, the pharmaceutical powerhouse feels put-upon by what its CEO calls America’s “uncompetitive tax rate.”